다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, v.94, 2020년, pp.119 - 124
Xie, Mingxuan (Department of Geriatrics) , Chen, Qiong (Department of Geriatrics)
AI-Helper
Abstract Background The rapid spread of the coronavirus disease 2019 (COVID-19), caused by a zoonotic beta-coronavirus entitled 2019 novel coronavirus (2019-nCoV), has become a global threat. Awareness of the biological features of 2019-nCoV should be updated in time and needs to be comprehensively...
Assiri A. Al-Tawfiq J.A. Al- Rabeeah A.A. Al-Rabiah F.A. Al-Hajjar S. Al-Barrak A. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study Lancet Infect Dis 13 2013 752 761 10.1016/S1473-3099(13)70204-4 23891402
Backer J.A. Klinkenberg D. Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020 Euro Surveill 2020 25 10.2807/1560- 7917.ES.2020.25.5.2000062
Badawi A. Ryoo S.G. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis Int J Infect Dis 49 2016 129 133 10.1016/j.ijid.2016.06.015 27352628
Bauch C.T. Lloyd-Smith J.O. Coffee M.P. Galvani A.P. Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future Epidemiology 16 2005 791 801 10.1097/01.ede.0000181633.80269.4c 16222170
Bauch C.T. Oraby T. Assessing the pandemic potential of MERS-CoV Lancet 382 2013 662 664 10.1016/S0140-6736(13)61504- 4 23831143
Chan J.F. Kok K.H. Zhu Z. Chu H. To K.K. Yuan S. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan Emerg Microbes Infect 9 2020 221 236 10.1080/22221751.2020.1719902 31987001
Chen J. Ling Y. Xi X.H. Liu P. Li F. Li T. Efficacies of lopinavir/ritonavir and abidol in the treatment of novel coronavirus pneumonia Chin J Epidemiol 38 2020 10.3760/cma.j.cn311365-20200210-00050 Epub E008
Chen N. Zhou M. Dong X. Qu J. Gong F. Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet 395 2020 507 513 10.1016/S0140-6736(20)30211-7 32007143
Chen Q. Wang L. Xie M. Li X. Recommendations for influenza and Streptococcus pneumoniae vaccination in elderly people in China Aging Med 0 2020 1 11 10.1002/agm2.12102
Coutard B. Valle C. de Lamballerie X. Canard B. Seidah N.G. Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade Antiviral Res 176 2020 104742 10.1016/j.antiviral.2020.104742
Cowling B.J. Park M. Fang V.J. Wu P. Leung G.M. Wu J.T. Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015 Euro Surveill 20 2015 7 13 10.2807/1560-7917.es2015.20.25.21163 26132767
Gao J. Tian Z. Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies Biosci Trends 14 1 2020 72 73 10.5582/bst.2020.01047 32074550
Gorbalenya A.E. Baker S.C. Baric R.S. RJd Groot Drosten C. Gulyaeva A.A. Severe acute respiratory syndrome-related coronavirus―The species and its viruses, a statement of the Coronavirus Study Group 2020 10.1101/2020.02.07.937862
Guan W.J. Ni Z.Y. Hu Y. Liang W.H. Ou C.Q. He J.X. Clinical Characteristics of Coronavirus Disease 2019 in China N Engl J Med 2020 10.1056/NEJMoa2002032 https://www.nejm.org/doi/full/10.1056/NEJMoa2002032?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed [accessed 28 Feb 2020]. In press.
Hoffmann M. Kleine-Weber H. Schroeder S. Kruger N. Herrler T. Erichsen S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically-proven protease inhibitor Cell 181 2 2020 271 280.e8 10.1016/j.cell.2020.02.052 32142651
Holshue M.L. DeBolt C. Lindquist S. Lofy K.H. Wiesman J. Bruce H. First Case of 2019 Novel Coronavirus in the United States N Engl J Med 382 10 2020 929 936 10.1056/NEJMoa2001191 32004427
Huang C. Wang Y. Li X. Ren L. Zhao J. Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 2020 497 506 10.1016/S0140-6736(20)30183-5 31986264
Jaillon S. Berthenet K. Garlanda C. Sexual dimorphism in innate immunity Clin Rev Allergy Immunol 56 2019 308 321 10.1007/s12016-017-8648-x 28963611
Ji W. Wang W. Zhao X. Zai J. Li X. Cross-species transmission of the newly identified coronavirus 2019- nCoV J Med Virol 92 2020 433 440 10.1002/jmv.25682 31967321
Lam T.T. Shum M.H. Zhu H.C. Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China 2020 10.1101/2020.02.13.945485
Le R.Q. Li L. Yuan W. Shord S.S. Nie L. Habtemariam B.A. FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome Oncologist 23 2018 943 947 10.1634/theoncologist.2018- 0028 29622697
Lessler J. Reich N.G. Brookmeyer R. Perl T.M. Nelson K.E. Cummings D.A. Incubation periods of acute respiratory viral infections: a systematic review Lancet Infect Dis 9 2009 291 300 10.1016/S1473-3099(09)70069- 6 19393959
Li Q. Guan X. Wu P. Wang X. Zhou L. Tong Y. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia N Engl J Med 2020 10.1056/NEJMoa2001316
Lipsitch M. Cohen T. Cooper B. Robins J.M. Ma S. James L. Transmission dynamics and control of severe acute respiratory syndrome Science 300 2003 1966 1970 10.1126/science.1086616 12766207
Liu Y. Gayle A.A. Wilder-Smith A. Rocklov J. The reproductive number of COVID-19 is higher compared to SARS coronavirus J Travel Med 27 2 2020 1 4 10.1093/jtm/taaa021
Lu R. Zhao X. Li J. Niu P. Yang B. Wu H. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Lancet 395 10224 2020 565 574 10.1016/S0140-6736(20)30251-8 32007145
Mair-Jenkins J. Saavedra- Campos M. Baillie J.K. Cleary P. Khaw F.M. Lim W.S. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis J Infect Dis 211 2015 80 90 10.1093/infdis/jiu396 25030060
Mulangu S. Dodd L.E. Davey R.T. Jr. Tshiani Mbaya O. Proschan M. Mukadi D. A randomized, controlled trial of ebola virus disease therapeutics N Engl J Med 381 2019 2293 2303 10.1056/NEJMoa1910993 31774950
Nichol K.L. Nordin J. Mullooly J. Lask R. Fillbrandt K. Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly N Engl J Med 348 2003 1322 1332 10.1056/NEJMoa025028 12672859
Nicholls J.M. Poon L.L. Lee K.C. Ng W.F. Lai S.T. Leung C.Y. Lung pathology of fatal severe acute respiratory syndrome Lancet 361 2003 1773 1778 10.1016/s0140-6736(03)13413-7 12781536
Nishiura H. Linton N.M. Akhmetzhanov A.R. Serial interval of novel coronavirus (2019-nCoV) infections MedRxiv(preprint) 2020 10.1101/2020.02.03.20019497 Submitted for publication https://www.medrxiv.org/content/10.1101/2020.02.03.20019497v2
Park J.E. Jung S. Kim A. Park J.E. MERS transmission and risk factors: a systematic review BMC Public Health 18 2018 574 10.1186/s12889-018-5484-8 29716568
Pei F. Zheng J. Gao Z.F. Zhong Y.F. Fang W.G. Gong E.C. Lung pathology and pathogenesis of severe acute respiratory syndrome: a report of six full autopsies Clin J Pathol 34 2005 656 660
Qian I. Rongshuai W. Guoqiang Q. Yunyun W. Pan L. Yingzhi Z. A report on the general observation of a 2019 novel coronavirus autopsy J Forensic Sci 36 2020 1 3 10.12116/j.issn.1004-5619.2020.01.00
Sheahan T.P. Sims A.C. Leist S.R. Schafer A. Won J. Brown A.J. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV Nat Commun 11 2020 222 10.1038/s41467-019-13940-6 31924756
Sui J. Li W. Murakami A. Tamin A. Matthews L.J. Wong S.K. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association Proc Natl Acad Sci U S A 101 2004 2536 2541 10.1073/pnas.0307140101 14983044
van Griensven J.F. Edwards T. de Lamballerie X. Semple M.G. Gallian P. Baize S. Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea N Engl J Med 374 2016 33 42 10.1056/NEJMoa1511812 26735992
Vincent M.J. Bergeron E. Benjannet S. Erickson B.R. Rollin P.E. Ksiazek T.G. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Virol J 2 2005 69 10.1186/1743-422X-2-69 16115318
Wang D. Hu B. Hu C. Zhu F. Liu X. Zhang J. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China JAMA 2020 10.1001/jama.2020.1585 In press https://jamanetwork.com/journals/jama/fullarticle/2761044
Wang M. Cao R. Zhang L. Yang X. Liu J. Xu M. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Cell Res 30 2020 269 271 10.1038/s41422-020-0282-0 32020029
WHO Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 2020 https://www.who.int/csr/sars/country/table2004_04_21/en/
WHO WHO MERS Global Summary and Assessment of Risk. 2020 https://www.who.int/csr/disease/coronavirus_infections/risk-assessment-august- 2018.pdf?ua=1
WHO Novel Coronavirus(2019-nCoV) Situation Report-51 2020 2020 https://www.who.int/docs/default- source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?
Wrapp D. Wang N. Corbett K.S. Goldsmith J.A. Hsieh C.-L. Abiona O. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Science 367 6483 2020 1260 1263 10.1126/science.abb2507 32075877
Wu A. Peng Y. Huang B. Ding X. Wang X. Niu P. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China Cell Host Microbe 27 3 2020 325 328 10.1016/j.chom.2020.02.001 32035028
Wu Z. McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention JAMA 2020 10.1001/jama.2020.2648 In press https://jamanetwork.com/journals/jama/fullarticle/2762130
Xu X. Chen P. Wang J. Feng J. Zhou H. Li X. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission Sci China Life Sci 63 3 2020 457 460 10.1007/s11427-020-1637-5 32009228
Xu Z. Shi L. Wang Y. Zhang J. Huang L. Zhang C. Pathological findings of COVID-19 associated with acute respiratory distress syndrome Lancet Respir Med 8 4 2020 420 422 10.1016/S2213-2600(20)30076-X 32085846
Yang Y. Liu M.J. Wang Y.X. Zhang A.R. Jalali Neda Dean Natalie Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China MedRxiv 2020 10.1101/2020.02.10.20021675 Submitted for publication https://www.medrxiv.org/content/10.1101/2020.02.10.20021675v2#disqus_thread
Yu W.B. Tang G.D. Zhang L. Corlett R.T. Decoding the evolution and transmissions of the novel pneumonia coronavirus (SARS-CoV-2) using whole genomic data ChinaXiv 2020 10.12074/202002.00033 Submitted for publication http://www.chinaxiv.org/abs/202002.00033
Zhao Yu Wang Y.J. Zhou Y.Q. Ma Y. Zuo Y. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov BioRxiv(preprint) 2020
Zhu N. Zhang D. Wang W. Li X. Yang B. Song J. A Novel Coronavirus from Patients with Pneumonia in China, 2019 N Engl J Med 382 2020 727 733 10.1056/NEJMoa2001017 31978945
Zumla A. Hui D.S. Azhar E.I. Memish Z.A. Maeurer M. Reducing mortality from 2019-nCoV: host-directed therapies should be an option Lancet 2020 10.1016/S0140-6736(20)30305-6
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.